retatrutide glp-1 gip glucagon agonist Synedica Retatrutide: The triple agonist powering
Description
doi: 10.1016/j.tem.2016.10.001 [DOI] [PubMed] [Google Scholar] 25
GIP is released from the upper small intestine in response to nutrients
Patients who rely solely on the medication without changing habits are nearly guaranteed to regain when they stop
Small tweaks to the molecular structures allow the medications to avoid breakdown and exert their effects for longer periods of time
Most people inject retatrutide once per week on the same day
doi: 10.1111/dom.12121
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
